Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia. [electronic resource]
Producer: 20150923Description: 1570-8 p. digitalISSN:- 2045-7634
- Age Factors
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Azacitidine -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Induction Chemotherapy
- Injections, Subcutaneous
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.